Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase.

Bone morphogenetic proteins (BMPs) induce osteoblastic differentiation in myogenic cells via the phosphorylation of Smads. Two types of Smad phosphatases--small C-terminal domain phosphatase 1 (SCP1) and protein phosphatase magnesium-dependent 1A--have been shown to inhibit BMP activity. Here, we report that SCP1 inhibits the osteoblastic differentiation induced by BMP-4, a constitutively active BMP receptor, and a constitutively active form of Smad1. The phosphatase activity of SCP1 was required for this suppression, and the knockdown of SCP1 in myoblasts stimulated the osteoblastic differentiation induced by BMP signaling. In contrast to protein phosphatase magnesium-dependent 1A, SCP1 did not reduce the protein levels of Smad1 and failed to suppress expression of the Id1, Id2, and Id3 genes. Runx2-induced osteoblastic differentiation was suppressed by SCP1 without affecting the transcriptional activity or phosphorylation levels of Runx2. Taken together, these findings suggest that SCP1 may inhibit the osteoblastic differentiation induced by the BMP-Smad axis via Runx2 by suppressing downstream effector(s).

[1]  A. Nordheim,et al.  Id Genes Are Direct Targets of Bone Morphogenetic Protein Induction in Embryonic Stem Cells* , 1999, The Journal of Biological Chemistry.

[2]  S. Pfaff,et al.  Small CTD Phosphatases Function in Silencing Neuronal Gene Expression , 2005, Science.

[3]  R. Kamijo,et al.  Purification and identification of a BMP-like factor from bovine serum. , 2006, Biochemical and biophysical research communications.

[4]  J. Deng,et al.  The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.

[5]  M. Kretzschmar,et al.  Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1 , 1997, Nature.

[6]  Y. Okazaki,et al.  Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. , 2009, The Journal of biological chemistry.

[7]  P. Hoodless,et al.  MADR1, a MAD-Related Protein That Functions in BMP2 Signaling Pathways , 1996, Cell.

[8]  T. Suda,et al.  Bone morphogenetic protein-2 does not alter the differentiation pathway of committed progenitors of osteoblasts and chondroblasts , 1996, Cell and Tissue Research.

[9]  J. Morgan,et al.  Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles , 2010, Developmental biology.

[10]  Xueyan Duan,et al.  PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling , 2006, Cell.

[11]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[12]  J. Wozney,et al.  Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12 , 2000, Molecular and Cellular Biology.

[13]  M. Urist.  Bone: Formation by Autoinduction , 1965, Science.

[14]  L. A. Goldman,et al.  Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. , 1996, BioTechniques.

[15]  Y. Okazaki,et al.  A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor. , 2008, Biochemical and biophysical research communications.

[16]  E. Robertis,et al.  Integrating Patterning Signals: Wnt/GSK3 Regulates the Duration of the BMP/Smad1 Signal , 2007, Cell.

[17]  N. Takahashi,et al.  Identification of a BMP‐responsive element in Id1, the gene for inhibition of myogenesis , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[18]  J. Massagué,et al.  Direct Binding of Smad1 and Smad4 to Two Distinct Motifs Mediates Bone Morphogenetic Protein-specific Transcriptional Activation ofId1 Gene* , 2002, The Journal of Biological Chemistry.

[19]  K. Miyazono,et al.  BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. , 2005, Cytokine & growth factor reviews.

[20]  P. Lin,et al.  A Novel RNA Polymerase II C-terminal Domain Phosphatase That Preferentially Dephosphorylates Serine 5* , 2003, Journal of Biological Chemistry.

[21]  K. Miyazono,et al.  5 The Bone Morphogenetic Proteins , 2008 .

[22]  V. Rosen,et al.  Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713] , 1994, The Journal of cell biology.

[23]  In Ho Choi,et al.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva , 2006, Nature Genetics.

[24]  Kozo Nakamura,et al.  Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[25]  Xu Cao,et al.  BMP signaling in skeletal development. , 2005, Biochemical and biophysical research communications.

[26]  T. Yoneda,et al.  Smad5 and DPC4 Are Key Molecules in Mediating BMP-2-induced Osteoblastic Differentiation of the Pluripotent Mesenchymal Precursor Cell Line C2C12* , 1998, The Journal of Biological Chemistry.

[27]  A. Brivanlou,et al.  Dephosphorylation of the Linker Regions of Smad1 and Smad2/3 by Small C-terminal Domain Phosphatases Has Distinct Outcomes for Bone Morphogenetic Protein and Transforming Growth Factor-β Pathways* , 2006, Journal of Biological Chemistry.

[28]  Xin-Hua Feng,et al.  Protein Serine/Threonine Phosphatase PPM1A Dephosphorylates Smad1 in the Bone Morphogenetic Protein Signaling Pathway*> , 2006, Journal of Biological Chemistry.

[29]  Y. Okazaki,et al.  Dual Roles of Smad Proteins in the Conversion from Myoblasts to Osteoblastic Cells by Bone Morphogenetic Proteins* , 2010, The Journal of Biological Chemistry.

[30]  Jeffrey L. Wrana,et al.  A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation , 1999, Nature.

[31]  G. Karsenty,et al.  Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene , 1995, Molecular and cellular biology.

[32]  S. Ohte,et al.  Protein phosphatase magnesium‐dependent 1A–mediated inhibition of BMP signaling is independent of Smad dephosphorylation , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[34]  W. Vale,et al.  Smad8 mediates the signaling of the receptor serine kinase , 1997 .

[35]  A. Brivanlou,et al.  Unique players in the BMP pathway: Small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling , 2006, Proceedings of the National Academy of Sciences.

[36]  P. Lengyel,et al.  The MyoD-Inducible p204 Protein Overcomes the Inhibition of Myoblast Differentiation by Id Proteins , 2002, Molecular and Cellular Biology.